Outpatient Vasodilator Assessment Using Iloprost in Pulmonary Hypertension

Summary

This study will compare the clinical efficacy of inhaled iloprost as an invasive, selective vasodilator in the cardiac catheterization laboratory in patients with pulmonary hypertension to the gold standard of inhaled nitric oxide. It will also examine whether echocardiographic estimates of response to inhaled iloprost can predict responsiveness to invasive vasodilator testing in patients with pulmonary hypertension.

Timeline

Start

2017-07-21

Primary completion

2019-06-20

Completion

2020-05-19

Drugs

Indications